| Year |
Citation |
Score |
| 2020 |
Sierra-Arregui T, Llorente J, Giménez Minguez P, Tønnesen J, Peñagarikano O. Neurobiological mechanisms of autism spectrum disorder and epilepsy, insights from animal models. Neuroscience. PMID 32147509 DOI: 10.1016/j.neuroscience.2020.02.043 |
0.334 |
|
| 2018 |
Parras A, Anta H, Santos-Galindo M, Swarup V, Elorza A, Nieto-González JL, Picó S, Hernández IH, Díaz-Hernández JI, Belloc E, Rodolosse A, Parikshak NN, Peñagarikano O, Fernández-Chacón R, Irimia M, et al. Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing. Nature. PMID 30111840 DOI: 10.1038/S41586-018-0423-5 |
0.39 |
|
| 2015 |
Peñagarikano O. New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences. Experimental Neurobiology. 24: 301-11. PMID 26713078 DOI: 10.5607/en.2015.24.4.301 |
0.317 |
|
| 2015 |
Berg JM, Lee C, Chen L, Galvan L, Cepeda C, Chen JY, Peñagarikano O, Stein JL, Li A, Oguro-Ando A, Miller JA, Vashisht AA, Starks ME, Kite EP, Tam E, et al. JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse. Neuron. PMID 26627310 DOI: 10.1016/J.Neuron.2015.10.031 |
0.649 |
|
| 2015 |
Gdalyahu A, Lazaro M, Penagarikano O, Golshani P, Trachtenberg JT, Geschwind DH. Correction: The Autism Related Protein Contactin-Associated Protein-Like 2 (CNTNAP2) Stabilizes New Spines: An In Vivo Mouse Study. Plos One. 10: e0129638. PMID 26024526 DOI: 10.1371/journal.pone.0129638 |
0.31 |
|
| 2015 |
Gdalyahu A, Lazaro M, Penagarikano O, Golshani P, Trachtenberg JT, Geschwind DH, Gescwind DH. The Autism Related Protein Contactin-Associated Protein-Like 2 (CNTNAP2) Stabilizes New Spines: An In Vivo Mouse Study. Plos One. 10: e0125633. PMID 25951243 DOI: 10.1371/journal.pone.0125633 |
0.338 |
|
| 2015 |
Chen JA, Peñagarikano O, Belgard TG, Swarup V, Geschwind DH. The emerging picture of autism spectrum disorder: genetics and pathology. Annual Review of Pathology. 10: 111-44. PMID 25621659 DOI: 10.1146/Annurev-Pathol-012414-040405 |
0.315 |
|
| 2012 |
Peñagarikano O, Geschwind DH. What does CNTNAP2 reveal about autism spectrum disorder? Trends in Molecular Medicine. 18: 156-63. PMID 22365836 DOI: 10.1016/j.molmed.2012.01.003 |
0.325 |
|
| 2004 |
Peñagarikano O, Gil A, Télez M, Ortega B, Flores P, Veiga I, Peixoto A, Criado B, Arrieta I. A new insight into fragile X syndrome among Basque population. American Journal of Medical Genetics. Part A. 128: 250-5. PMID 15216545 DOI: 10.1002/ajmg.a.30116 |
0.493 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
Peñagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, Sonnenblick LI, Gruver R, Almajano J, Bragin A, Golshani P, Trachtenberg JT, Peles E, Geschwind DH. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell. 147: 235-46. PMID 21962519 DOI: 10.1016/J.Cell.2011.08.040 |
0.299 |
|
| 2017 |
Peñagarikano O. Oxytocin in animal models of autism spectrum disorder. Developmental Neurobiology. 77: 202-213. PMID 27603327 DOI: 10.1002/dneu.22449 |
0.259 |
|
| 2019 |
Möhrle D, Fernández M, Peñagarikano O, Frick A, Allman B, Schmid S. What we can learn from a genetic rodent model about autism. Neuroscience and Biobehavioral Reviews. PMID 31887338 DOI: 10.1016/J.Neubiorev.2019.12.015 |
0.249 |
|
| 2019 |
Lazaro MT, Taxidis J, Shuman T, Bachmutsky I, Ikrar T, Santos R, Marcello GM, Mylavarapu A, Chandra S, Foreman A, Goli R, Tran D, Sharma N, Azhdam M, Dong H, et al. Reduced Prefrontal Synaptic Connectivity and Disturbed Oscillatory Population Dynamics in the CNTNAP2 Model of Autism. Cell Reports. 27: 2567-2578.e6. PMID 31141683 DOI: 10.1016/J.Celrep.2019.05.006 |
0.24 |
|
| 2015 |
Peñagarikano O, Lázaro MT, Lu XH, Gordon A, Dong H, Lam HA, Peles E, Maidment NT, Murphy NP, Yang XW, Golshani P, Geschwind DH. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Science Translational Medicine. 7: 271ra8. PMID 25609168 DOI: 10.1126/Scitranslmed.3010257 |
0.232 |
|
| 2021 |
Fernández M, Sánchez-León CA, Llorente J, Sierra-Arregui T, Knafo S, Márquez-Ruiz J, Peñagarikano O. Altered cerebellar response to somatosensory stimuli in the mouse model of autism. Eneuro. PMID 34593517 DOI: 10.1523/ENEURO.0333-21.2021 |
0.204 |
|
| 2020 |
DelaCuesta-Barrutia J, Peñagarikano O, Erdozain AM. G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism. Frontiers in Cellular Neuroscience. 14: 588662. PMID 33192330 DOI: 10.3389/fncel.2020.588662 |
0.181 |
|
| 2017 |
Peñagarikano O. Your genes are conspiring against you. Science Translational Medicine. 9. PMID 28179504 DOI: 10.1126/scitranslmed.aam6059 |
0.15 |
|
| 2015 |
Kloth AD, Badura A, Li A, Cherskov A, Connolly SG, Giovannucci A, Bangash MA, Grasselli G, Peñagarikano O, Piochon C, Tsai PT, Geschwind DH, Hansel C, Sahin M, Takumi T, et al. Cerebellar associative sensory learning defects in five mouse autism models. Elife. 4. PMID 26158416 DOI: 10.7554/Elife.06085 |
0.144 |
|
| 2024 |
DelaCuesta-Barrutia J, Hidema S, Caldwell HK, Nishimori K, Erdozain AM, Peñagarikano O. In need of a specific antibody against the oxytocin receptor for neuropsychiatric research: A KO validation study. Journal of Psychiatric Research. 173: 260-270. PMID 38554622 DOI: 10.1016/j.jpsychires.2024.03.028 |
0.119 |
|
| 2021 |
Choe KY, Bethlehem RAI, Safrin M, Dong H, Salman E, Li Y, Grinevich V, Golshani P, DeNardo LA, Peñagarikano O, Harris NG, Geschwind DH. Oxytocin normalizes altered circuit connectivity for social rescue of the Cntnap2 knockout mouse. Neuron. PMID 34932941 DOI: 10.1016/j.neuron.2021.11.031 |
0.119 |
|
| 2020 |
Soria FN, Miguelez C, Peñagarikano O, Tønnesen J. Current Techniques for Investigating the Brain Extracellular Space. Frontiers in Neuroscience. 14: 570750. PMID 33177979 DOI: 10.3389/fnins.2020.570750 |
0.112 |
|
| 2017 |
Fernández M, Mollinedo-Gajate I, Peñagarikano O. Neural circuits for social cognition: Implications for Autism. Neuroscience. PMID 28729065 DOI: 10.1016/j.neuroscience.2017.07.013 |
0.111 |
|
| 2015 |
Burkett ZD, Day NF, Peñagarikano O, Geschwind DH, White SA. VoICE: A semi-automated pipeline for standardizing vocal analysis across models. Scientific Reports. 5: 10237. PMID 26018425 DOI: 10.1038/Srep10237 |
0.111 |
|
| 2015 |
Wei D, Lee D, Cox CD, Karsten CA, Peñagarikano O, Geschwind DH, Gall CM, Piomelli D. Endocannabinoid signaling mediates oxytocin-driven social reward. Proceedings of the National Academy of Sciences of the United States of America. PMID 26504214 DOI: 10.1073/Pnas.1509795112 |
0.109 |
|
| 2007 |
Penagarikano O, Mulle JG, Warren ST. The pathophysiology of fragile X syndrome Annual Review of Genomics and Human Genetics. 8: 109-129. PMID 17477822 DOI: 10.1146/Annurev.Genom.8.080706.092249 |
0.103 |
|
| 2017 |
Lissek T, Adams M, Adelman J, Ahissar E, Akaaboune M, Akil H, al'Absi M, Arain F, Arango-Lasprilla JC, Atasoy D, Avila J, Badawi A, Bading H, Baig AM, Baleriola J, ... ... Penagarikano O, et al. Building Bridges through Science. Neuron. 96: 730-735. PMID 29144972 DOI: 10.1016/J.Neuron.2017.09.028 |
0.039 |
|
| 2003 |
Arrieta I, Martínez B, Criado B, Télez M, Ortega B, Peñagarikano O, Lostao CM. Dermatoglyphic variation in Spanish Basque populations. Human Biology. 75: 265-91. PMID 12943163 DOI: 10.1353/hub.2003.0029 |
0.029 |
|
| 2019 |
Erdozain AM, Peñagarikano O. Oxytocin as Treatment for Social Cognition, Not There Yet. Frontiers in Psychiatry. 10: 930. PMID 31998152 DOI: 10.3389/fpsyt.2019.00930 |
0.016 |
|
| 2016 |
Peñagarikano O. Stress: A deadly weapon. Science Translational Medicine. 8: 370ec204. PMID 28003543 DOI: 10.1126/scitranslmed.aal3703 |
0.01 |
|
| Hide low-probability matches. |